Replimune Group appoints Chris Sarchi as CCO, Sushil Patel as CSO
The Fly

Replimune Group appoints Chris Sarchi as CCO, Sushil Patel as CSO

Replimune Group (REPL) announced the appointment of Christopher Sarchi as Replimune’s Chief Commercial Officer and the appointment of Sushil Patel, Ph.D., previously Replimune’s Chief Commercial Officer, to a newly created position of Chief Strategy Officer, effective immediately. Chris joins Replimune having recently served as Head of Commercial U.S. Oncology at Sanofi (SNY) where he was responsible for several launches, including the launch of Libtayo as a new standard of care treatment for CSCC.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on REPL:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App